Outcome of the Extra Ordinary General Meeting dated 22nd October, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals held an Extra-Ordinary General Meeting (EGM) on October 22, 2025, via video conferencing from 9:00 a.m. to 9:20 a.m. The main item discussed was a proposal to issue Equity Shares and Convertible Warrants on a preferential basis, to be passed as a Special Resolution. Dr. Mrs. Daulat Nariman Medhora chaired the meeting. Remote e-voting was already conducted between October 19 and October 21, 2025, with an additional 15-minute window during the meeting. The Chairman briefed shareholders on the proposed issue and the intended use of proceeds, and addressed shareholder questions. The final e-voting results and Scrutiniser's Report will be filed separately with the stock exchanges.
The preferential issue of equity shares and convertible warrants, if approved, will dilute existing shareholders' ownership and bring fresh capital into the company. Investors should watch for the e-voting results, which will confirm whether the special resolution was passed.